'Load points' and 'choke points' as nodes for prioritizing drug targets in Pseudomonas aeruginosa

Current Bioinformatics

Volumn 4, Issue 1, 2009, Pages 48-53

  Perumal, Deepak ^a,b   Lim, Chu Sing ^b   Sakharkar, Kishore R ^b,c   Sakharkar, Meena K ^a,b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c OmicsVista   (Singapore)

Author keywords

Choke points; Load points; P. aeruginosa; Pathway Hunter Tool (PHT)

Indexed keywords

METABOLISM; SYSTEMS ANALYSIS;

BIOLOGICAL PATHWAYS; CHOKE POINTS; DRUG TARGETS; GENOMIC-SEQUENCE DATA; LOAD POINTS; METABOLIC NETWORK; METABOLIC PATHWAYS; P.AERUGINOSA; PATHWAY HUNTER TOOL; PSEUDOMONAS AERUGINOSA;

ENZYMES;

ACETYL COENZYME A SYNTHETASE; ACYLPHOSPHATASE; ADENINE PHOSPHORIBOSYLTRANSFERASE; ANTIINFECTIVE AGENT; ASPARTATE AMINOTRANSFERASE; BACTERIAL ENZYME; ENOLASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NUCLEOSIDE DIPHOSPHATE KINASE A; TRANSKETOLASE;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL; BACTERIAL GENOME; BACTERIAL METABOLISM; DRUG TARGETING; ENZYME ANALYSIS; GENE FUNCTION; GENE SEQUENCE; HOST; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SITE DIRECTED MUTAGENESIS;

PSEUDOMONAS AERUGINOSA;

EID: 65349150645     PISSN: 15748936     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489309787158189     Document Type: Review

References (31)

1. Schmid MB. Novel approaches to the discovery of antimicrobial agents. Curr Opin Chem Biol 1998; 2: 529-534.
2. Read TD, Gill SR, Tettelin H, Dougherty BA. Finding drug targets in microbial genomes. Drug Discov Today 2001; 6: 887-892.
3. Schmid MB. Crystallizing new approaches for antimicrobial drug discovery. Biochem Pharmacol 2006; 71: 1048-1056.
4. Galperin MY, Koonin EV. Searching for drug targets in microbial genomes. Curr Opin Biotechnol 1999; 10: 571-578.
5. Sakharkar KR, Sakharkar MK, Chow VTK. A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. Silico Biol 2004; 4: 355-360.
6. Galperin MY, Koonin EV. 'Conserved hypothetical' proteins: Prioritization of targets for experimental study. Nucleic Acids Res 2004; 32: 5452-5463.
7. Kobayashi K, Ehrlich SD, Albertini A, et al. Essential Bacillus subtilis genes. Proc Natl Acad Sci USA 2003; 100: 4678-4683.
8. Koonin EV, Tatusov RL, Galperin MY. Beyond complete genomes: From sequence to structure and function. Curr Opin Struct Biol 1998; 8: 355-363.
9. Ogata H, Goto S, Sato K, et al. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 1999; 27: 29-34.
10. Price ND, Reed J, Palsson BO. Genome-scale models of microbial cells: Evaluating the consequences of constraints. Nat Rev Microbiol 2004; 2: 886-897.
11. Bono H, Ogata H, Goto S, Kanehisa M. Reconstruction of amino acid biosynthesis pathways from the complete genome sequence. Genome Res 1998; 8: 203-210.
12. Arigoni F, Talabot F, Peitsch M, et al. A genome-based approach for the identification of essential bacterial genes. Nat Biotechnol 1998; 16: 851-856.
13. Ma H, Zeng AP. Reconstruction of metabolic networks from genome data and analysis of their global structure for various organisms. Bioinformatics 2003; 19: 270-277.
14. Oltvai ZN, Barabasi AL. Systems biology: Life's complexity pyramid. Science 2002; 298: 763-764.
15. Schuster S, Fell DA, Dandekar T. A general definition of metabolic pathways useful for systematic organization and analysis of complex metabolic networks. Nat Biotechnol 2000; 18: 326-332.
16. Barabasi AL, Oltvai ZN. Network biology: Understanding the cell's functional organization. Nat Rev Genet 2004; 5: 101-113.
17. Palumbo MC, Colosimo A, Giuliani A, Farina L. Functional essentiality from topology features in metabolic networks: A case study in yeast. FEBS Lett 2005; 579: 4642-4646.
18. Palumbo MC, Colosimo A, Giuliani A, Farina L. Essentiality is an emergent property of metabolic network wiring. FEBS Lett 2007; 581: 2485-2489.
19. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000; 406: 959-964.
20. Hutchison ML, Govan JRW. Pathogenicity of microbes associated with cystic fibrosis. Microbes Infect 1999; 1: 1005-1014.
21. Perumal D, Lim CS, Sakharkar KR, Sakharkar MK. Differential genome analyses of metabolic enzymes in pseudomonas aeruginosa for drug target identification. Silico Biol 2007; 7: 453-465.
22. Rahman SA, Advani P, Schunk R, Schrader R, Schomburg D. Metabolic pathway analysis web service (Pathway Hunter Tool at CUBIC). Bioinformatics 2005; 21: 1189-1193.
23. Rahman SA, Schomburg D. Observing local and global properties of metabolic pathways: 'Load points' and 'choke points' in the metabolic networks. Bioinformatics 2006; 22: 1767-1774.
24. Jeong H, Tombor B, Albert R, Oltval ZN, Barabasi AL. The large-scale organization of metabolic networks. Nature 2000; 407: 651-654.
25. Yeh I, Hanekamp T, Tsoka S, Karp PD, Altman RB. Computational analysis of Plasmodium falciparum metabolism: Organizing genomic information to facilitate drug discovery. Genome Res 2004; 14: 917-924.
26. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
27. Kanehisa M, Goto S, Kawashima S, Nakaya A. The KEGG databases at GenomeNet. Nucleic Acids Res 2002; 30: 42-46.
28. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-3402.
29. Perumal D, Lim CS, Chow VTK, Sakharkar KR, Sakharkar MK. A combined computational-experimental analyses of selected metabolic enzymes in Pseudomonas species. Int J Biol Sci 2008; 4: 309-317.
30. Hellerstein MK. A critique of the molecular target-based drug discovery paradigm based on principles of metabolic control: Advantages of pathway-based discovery. Metab Eng 2008; 10: 1-9.
31. Sakharkar KR, Sakharkar MK, Chow VT. Gene conservation and Gene Loss in obligatory intracellular parasites, Curr BioInform 2007; 2: 214-221.